/

Companies / Avalyn

Avalyn

United States

Avalyn Pharma develops inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Avalyn, based in United States, has 9 investors on file, among them Catalio Capital Management, F-Prime Capital and Global Source Ventures. Its site was last checked 12 Nov 2026: site answers.

Investors

9 investors on file
InvestorEvidenceType
Catalio Capital ManagementPortfolio pageVenture capital
F-Prime CapitalPortfolio pageVenture capital
Global Source VenturesPortfolio pageVenture capital
InVivium CapitalPortfolio pageVenture capital
NorwestPortfolio pageVenture capital
Pivotal Life SciencesPortfolio pageVenture capital
SR OnePortfolio pageVenture capital
Vida VenturesPortfolio pageVenture capital
XontogenyPortfolio pageAccelerator

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Avalyn and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Catalio Capital Management adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/avalynpharma.com/investors

# also
GET /v1/companies/avalynpharma.com
GET /v1/companies/avalynpharma.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing